Clayton, Dubilier & Rice announced today that Eric Rouzier has been named a Partner of the Firm.
Over his 12-year career at CD&R, Mr. Rouzier has been actively involved in sourcing and evaluating new investments across Europe, as well as working with portfolio company management teams on post-acquisition value-building strategies and execution. He leads the Firm's healthcare investment effort in Europe and has played a leadership role in connection with several of the Firm's European investments, including Belron (2017), Spie (2011), Exova (2008), and Rexel (2005).
Mr. Rouzier joined CD&R in 2005 from JP Morgan and is a graduate of the ENSAM Graduate School of Engineering and ESSEC Graduate School of Management in Paris.
"Eric's appointment to Partner is well deserved," said David A. Novak, the Partner who leads CD&R's European team. "He has demonstrated strong leadership skills and investment judgement, and he embodies the values that are core to CD&R's model."
About Clayton, Dubilier & Rice
Founded in 1978, Clayton, Dubilier & Rice is a private investment firm with an investment strategy predicated on producing financial returns through building stronger, more profitable businesses. Since inception, CD&R has managed the investment of $24 billion in 76 companies, representing a broad range of industries with an aggregate transaction value in excess of $100 billion. The Firm has offices in New York and London. For more information, visit www.cdr-inc.com.
SOURCE Clayton, Dubilier & Rice